Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
Recruiting · NCT05342584 · Registry updated 2026-01-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-01-08 | NCT05342584 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
| Dana-Farber Cancer Institute | 324 |
| Montefiore Medical Center | 93 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM) | The Bronx | United States | 1 |